Epidemiology


Etiology


  • Preterm birth (< 38 weeks gestation).
  • Suboptimal breastfeeding/lactation failure.
  • Hemolytic disease (e.g., ABO/Rh incompatibility, G6PD deficiency).
  • East Asian ethnicity.
  • Significant bruising or cephalohematoma (increases RBC turnover). c
  • Maternal gestational DM.

Pathophysiology


Physiological neonatal jaundice

  1. ↑ Bilirubin production: ↑ RBC mass/hematocrit at birth with a shorter RBC lifespan (~90 days vs. 120 days).
  2. ↓ Bilirubin clearance: Transiently ↓ activity of hepatic UDP-glucuronosyltransferase (UGT1A1) (takes ~2 weeks to reach adult levels). c
  3. ↑ Enterohepatic circulation: Sterile newborn gut lacks bacteria to convert bilirubin to urobilinogen; high intestinal β-glucuronidase deconjugates bilirubin, allowing reabsorption.

Subtypes and variants


Breastfeeding jaundice (Lactation failure jaundice)

  • Definition: a type of neonatal jaundice caused by insufficient breastfeeding
  • Pathophysiology: insufficient breast milk intake → lack of calories and inadequate quantities of bowel movements to remove bilirubin from the body → ↑ enterohepatic circulation → increased reabsorption of bilirubin from the intestines → unconjugated hyperbilirubinemia
  • Clinical features: onset within 1 week

Breast milk jaundice

  • Definition: a type of neonatal jaundice caused by increased levels of β-glucuronidase in maternal breast milk
  • Pathophysiology: increased concentration of β-glucuronidase in breast milk → ↑ deconjugation and reabsorption of bilirubin → persistence of physiologic jaundice with unconjugated hyperbilirubinemia c
    • β-Glucuronidase is found in breast milk and the intestinal brush border.
    • Deconjugation of bilirubin by bacterial β-glucuronidase can lead to pigment stone formation.
  • Clinical features: onset within 2 weeks after birth; lasts for 4–13 weeks
    • Healthy, thriving infant with appropriate weight gain.
    • Normal hydration status (wet diapers, moist mucous membranes).
    • Progressive jaundice (cephalocaudal progression).
    • Normal-colored stools (not pale/acholic) and light-colored urine.
  • Diagnostics: Unconjugated (indirect) hyperbilirubinemia with normal direct bilirubin (< 1.0 mg/dL or < 10% of total).
  • Treatment
    1. Reassurance & Continue Breastfeeding: First-line.
      • Encourage maternal hydration and frequent feeding (8-12 times/day) to promote GI motility and stooling. c
    2. Phototherapy:
      • Initiated if TSB levels exceed the age-specific phototherapy threshold based on the AAP nomogram.
    3. Temporary cessation of breastfeeding:
      • Only indicated if TSB approaches exchange transfusion thresholds. Substitute with formula for 24-48 hours to abruptly lower bilirubin, then resume breastfeeding.

Clinical features


Diagnostics


Treatment


Complications


Kernicterus (chronic bilirubin encephalopathy)

  • Develops over first years of life
  • Pathophysiology: deposition of unconjugated bilirubin (liposoluble) in the basal ganglia and/or brain stem nuclei
  • Clinical features
    • Cerebral paresis, hearing impairment, vertical gaze palsy
    • Movement disorder (choreoathetosis)